Executive Director, Clinical Development

The Company is seeking an Executive Director of Clinical Development to help shape clinical strategy across its oncology portfolio and support the execution of global clinical programs. The role partners with senior clinical leaders and study teams to develop study plans, guide early-stage trials, and interpret emerging safety, efficacy, pharmacology, and translational data. Responsibilities include contributing to study design and reporting, reviewing safety signals and benefit-risk, and providing medical-monitoring support. The Executive Director also supports regulatory and executive communications, builds relationships with investigators and external experts, and collaborates across functions to advance sound clinical decisions and patient safety. Candidates must hold an MD or MD/PhD and bring substantial oncology clinical development experience, including approximately 10 or more years in clinical research and drug development. Required qualifications include a strong clinical safety and medical-monitoring background, experience leading interventional studies and global trials, and deep knowledge of early development, including first-in-human studies and dose optimization. Candidates should also have experience contributing to regulatory documents and health authority interactions, working knowledge of GCP, and the ability to translate complex evidence into clear recommendations. Board certification or eligibility in medical oncology or hematology/oncology, experience with solid tumors or antibody-drug conjugates, and experience preparing executive presentations or supporting scientific advisory boards are preferred.